BMEA stock · CVS stock

BMEA vs CVS

Biomea Fusion Inc (BMEA) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.

Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.

CVS Health Corp (CVS) is a healthcare plans company listed on US.

BMEA does not have a complete income-statement cache yet.

Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.

BMEA currently screens at market cap $94.7M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.

Not investment advice. Open the BMEA and CVS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons